drugset / Trial / NCT00640003

Baclofen Treatment of Ataxia Telangiectasia

NCT00640003

Phase 0 Completed 10 enrolled Johns Hopkins University
RandomizedCrossoverTriple-blindTreatment

Summary

This research is being done to find out if Baclofen, a medicine that is often used for the treatment of abnormal stiffness, might also be useful to treat some of the neurologic problems caused by ataxia telangiectasia (A-T). The investigators also want to find out if there are better ways to measure the problems of ataxia and abnormal eye movement for future studies of medication in ataxia telangiectasia.

Timeline

Start
2007-04
Primary completion
2011-02
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Baclofen Small molecule 10 mg Oral

Indications